Vasoregulation by IP3 receptor coupling to TRPC channels

通过 IP3 受体与 TRPC 通道偶联进行血管调节

基本信息

项目摘要

Arterial diameter, a principal modulator of systemic blood pressure and organ blood flow is regulated by changes in the contractility of arterial myocytes. The contractile status of arterial myocytes is determined by several local and global intracellular calcium ([Ca2+]i) signals. Ca2+ signal and diameter regulation by inositol 1,4,5-trisphophate (IP3), a phospholipase C-generated second messenger is poorly understood. The conventional view has been that IP3 constricts arteries by stimulating sarcoplasmic reticulum (SR) Ca2+ release in myocytes. Our recently published data indicated a novel mechanism of IP3-induced vasoconstriction that occurred independently of SR Ca2+ release, and via IP3 receptor (IP3R)- and canonical transient receptor potential (TRPC) 3-dependent cation current (ICat) activation. However, mechanisms by which IP3R activation stimulates TRPC channels in arterial myocytes to regulate arterial diameter are unclear. Preliminary data suggest that physical coupling between myocyte IP3Rs and TRPC3 channels regulates IP3-induced vasoconstriction. Data also indicate that arterial myocyte caveolae facilitate this IP3R-TRPC channel vasoregulatory mechanism. The central hypothesis of this proposal is that in cerebral artery myocytes, caveolae facilitate TRPC3 channel coupling with IP3Rs to mediate vasoconstrictor and IP3-induced membrane depolarization, voltage-dependent Ca2+ channel activation, [Ca2+]i elevation, and contraction. This proposal will investigate 3 specific aims: Aim 1 will test the hypothesis that in cerebral artery myocytes, IP3R to TRPC3 channel physical coupling is required for IP3-induced ICat activation. Aim 2 will test the hypothesis that IP3R to TRPC3 coupling mediates IP3-induced membrane depolarization, [Ca2+]i elevation, and constriction in cerebral arteries. Aim 3 will examine the hypothesis that arterial myocyte caveolae mediate physical and functional coupling of TRPC3 channels to IP3Rs. Experiments to study these aims will integrate techniques performed at molecular, cellular, and intact tissue levels, including Ca2+ imaging, FRET, electrophysiology, pressurized artery myography, and gene suppression.
动脉直径是调节全身血压和器官血流的主要调节因子

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adebowale Adebiyi其他文献

Adebowale Adebiyi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adebowale Adebiyi', 18)}}的其他基金

Urotensin II and renal insufficiency in growth-restricted infants.
尾加压素 II 和生长受限婴儿的肾功能不全。
  • 批准号:
    10264070
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10591881
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10594479
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    10341119
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10392350
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Urotensin II and renal insufficiency in growth-restricted infants.
尾加压素 II 和生长受限婴儿的肾功能不全。
  • 批准号:
    10469433
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    9884233
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    10565955
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10201230
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10808238
  • 财政年份:
    2020
  • 资助金额:
    $ 11.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了